Drugs / Compound Kushen Injection
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04204382 | Dec 2019 → Sep 2022 | mucositis | Shanxi Zhendong Pharmacy Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound Kushen Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04204382 ↗ |
| Known as | CKI | “Compound Kushen Injection（CKI）” NCT04204382 ↗ |